Comment on CMS-2026-1255-0001

Summary: The Society of General Internal Medicine (SGIM) supports CMS's efforts to modernize prior authorization through electronic processes and transparency but argues that further reforms are needed. They advocate for real-time adjudication, more granular reporting of metrics at the drug-specific level, and the inclusion of prior authorization performance in Medicare Advantage Star Ratings.